Houlihan, Catherine F.
University College London Hospitals NHS Foundation Trust
7 papers on CoChatORCID 0000-0002-7539-1566
Most cited papers
- Verified
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Voysey, M., Clemens, S. A. C., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B., Baillie, V. L., Barnabas, S. L., Bhorat, Q. E., et al. (2021) · The Lancet
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 4,616
- Verified
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
Voysey, M., Costa Clemens, S. A., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B., Baillie, V. L., Barnabas, S. L., Bhorat, Q. E., et al. (2021) · The Lancet
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 1,119
- Verified
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans
Ng, K. W., Faulkner, N., Cornish, G. H., Rosa, A., Harvey, R., Hussain, S., Ulferts, R., Earl, C., Wrobel, A. G., Benton, D. J., et al. (2020) · Science
SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testing
Cited by 886
- Verified
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
Willett, B. J., Grove, J., MacLean, O. A., Wilkie, C., De Lorenzo, G., Furnon, W., Cantoni, D., Scott, S., Logan, N., Ashraf, S., et al. (2022) · Nature Microbiology
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 785
- Verified
Amyloid processing in COVID‐19‐associated neurological syndromes
Ziff, O. J., Ashton, N. J., Mehta, P. R., Brown, R., Athauda, D., Heaney, J., Heslegrave, A. J., Benedet, A. L., Blennow, K., Checkley, A. M., et al. (2022) · Journal of Neurochemistry
Long-Term Effects of COVID-19Infectious Encephalopathies and Encephalitis
Cited by 54
- Verified
Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains
Faulkner, N., Ng, K. W., Wu, M. Y., Harvey, R., Margaritis, M., Paraskevopoulou, S., Houlihan, C., Hussain, S., Greco, M., Bolland, W., et al. (2021) · eLife
SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies
Cited by 52
- Verified
Advances in molecular diagnostic testing for central nervous system infections
Houlihan, C. F., Bharucha, T., & Breuer, J. (2019) · Current Opinion in Infectious Diseases
Bacterial Identification and Susceptibility TestingBacterial Infections and Vaccines
Cited by 24
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free